Bio-Path Holdings, Inc. (BPTH)
OTCMKTS
· Delayed Price · Currency is USD
0.0552
-0.0098 (-15.08%)
Apr 29, 2026, 1:19 PM EST
Bio-Path Holdings Employees
Bio-Path Holdings had 1 employees as of December 31, 2025. The number of employees decreased by 9 or -90.00% compared to the previous year.
Employees
1
Change (1Y)
-9
Growth (1Y)
-90.00%
Revenue / Employee
n/a
Profits / Employee
-$8,674,000
Market Cap
579.77K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Eloxx Pharmaceuticals | 10 |
| Emmaus Life Sciences | 33 |
| CNBX Pharmaceuticals | 1 |
| Hepion Pharmaceuticals | 2 |
| Altamira Therapeutics | 11 |
| Actavia Life Sciences | 1 |
Bio-Path Holdings News
- 11 months ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25 - Newsfile Corp
- 11 months ago - Bio-Path Holdings Provides Clinical and Operational Update - GlobeNewsWire
- 11 months ago - Bio-Path Holdings Transcript: Status Update - Transcripts
- 1 year ago - Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025 - GlobeNewsWire
- 1 year ago - Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients - GlobeNewsWire
- 1 year ago - Bio-Path Holdings Reports Full Year 2024 Financial Results - GlobeNewsWire
- 1 year ago - Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients - GlobeNewsWire
- 1 year ago - Bio-Path Holdings Provides Key Clinical Updates - GlobeNewsWire